By 2019, several genome-wide association studies had firmly established PNPLA3 I148M as a genetic modifier of steatosis in the liver and a risk factor for steatohepatitis, fibrosis, and HCC [34,35]. The gene discussed is PNPLA3; the disease is hepatocellular carcinoma.